Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6545 | 1471 | 46.1 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
329 | 3 | MENINGIOMA//NEUROSURG//JOURNAL OF NEURO-ONCOLOGY | 38091 |
102 | 2 | GLIOBLASTOMA//GLIOMA//MEDULLOBLASTOMA | 25713 |
6545 | 1 | EGFRVIII//EGFR AMPLIFICATION//GLIOBLASTOMA | 1471 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | EGFRVIII | authKW | 1025761 | 6% | 53% | 93 |
2 | EGFR AMPLIFICATION | authKW | 179611 | 1% | 58% | 15 |
3 | GLIOBLASTOMA | authKW | 169606 | 15% | 4% | 224 |
4 | ASTROCYTOMA | authKW | 144067 | 8% | 6% | 113 |
5 | GLIOMA | authKW | 116288 | 16% | 2% | 232 |
6 | GLIOBLASTOMA MULTIFORME | authKW | 97765 | 7% | 5% | 96 |
7 | GEMISTOCYTES | authKW | 93401 | 0% | 75% | 6 |
8 | ONCOGEN SIGNALLING | address | 93395 | 1% | 50% | 9 |
9 | EPIDERMAL GROWTH FACTOR RECEPTOR | authKW | 84611 | 8% | 3% | 123 |
10 | DELTA EGFR | authKW | 83026 | 0% | 100% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 16741 | 55% | 0% | 807 |
2 | Clinical Neurology | 5354 | 27% | 0% | 397 |
3 | Pathology | 4500 | 16% | 0% | 236 |
4 | Genetics & Heredity | 1292 | 13% | 0% | 198 |
5 | Neurosciences | 607 | 14% | 0% | 207 |
6 | Cell Biology | 427 | 11% | 0% | 156 |
7 | Surgery | 212 | 9% | 0% | 127 |
8 | Biochemistry & Molecular Biology | 57 | 10% | 0% | 149 |
9 | Medical Laboratory Technology | 16 | 1% | 0% | 12 |
10 | Medicine, Research & Experimental | 15 | 2% | 0% | 36 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGEN SIGNALLING | 93395 | 1% | 50% | 9 |
2 | SECUENCIAC AUTOMAT | 62270 | 0% | 100% | 3 |
3 | SAN DIEGO BRANCH | 57485 | 1% | 21% | 13 |
4 | EPITHELIAL BIOCHEM | 57473 | 0% | 46% | 6 |
5 | TUMOR TARGETING PROGRAM | 51886 | 0% | 50% | 5 |
6 | MEDHERTIE CLIN BRAIN | 41513 | 0% | 100% | 2 |
7 | WINSHIP BRAIN TUMOR | 41513 | 0% | 100% | 2 |
8 | PREUSS BRAIN TUMOR | 41509 | 0% | 50% | 4 |
9 | UNIT TUMOR PATHOL | 41509 | 0% | 50% | 4 |
10 | HENRY E SINGLETON BRAIN TUMOR PROGRAM | 39910 | 0% | 38% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEURO-ONCOLOGY | 25187 | 6% | 2% | 81 |
2 | CANCER GENETICS AND CYTOGENETICS | 11783 | 4% | 1% | 59 |
3 | GENES CHROMOSOMES & CANCER | 9914 | 3% | 1% | 39 |
4 | DEVELOPMENTS IN ONCOLOGY | 8732 | 2% | 2% | 23 |
5 | JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 8049 | 2% | 1% | 35 |
6 | BRAIN PATHOLOGY | 6668 | 1% | 1% | 22 |
7 | NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY | 3627 | 1% | 1% | 18 |
8 | CANCER RESEARCH | 3563 | 6% | 0% | 83 |
9 | ONCOGENE | 2919 | 3% | 0% | 51 |
10 | NEUROPATHOLOGY | 2819 | 1% | 1% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EGFRVIII | 1025761 | 6% | 53% | 93 | Search EGFRVIII | Search EGFRVIII |
2 | EGFR AMPLIFICATION | 179611 | 1% | 58% | 15 | Search EGFR+AMPLIFICATION | Search EGFR+AMPLIFICATION |
3 | GLIOBLASTOMA | 169606 | 15% | 4% | 224 | Search GLIOBLASTOMA | Search GLIOBLASTOMA |
4 | ASTROCYTOMA | 144067 | 8% | 6% | 113 | Search ASTROCYTOMA | Search ASTROCYTOMA |
5 | GLIOMA | 116288 | 16% | 2% | 232 | Search GLIOMA | Search GLIOMA |
6 | GLIOBLASTOMA MULTIFORME | 97765 | 7% | 5% | 96 | Search GLIOBLASTOMA+MULTIFORME | Search GLIOBLASTOMA+MULTIFORME |
7 | GEMISTOCYTES | 93401 | 0% | 75% | 6 | Search GEMISTOCYTES | Search GEMISTOCYTES |
8 | EPIDERMAL GROWTH FACTOR RECEPTOR | 84611 | 8% | 3% | 123 | Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR | Search EPIDERMAL+GROWTH+FACTOR+RECEPTOR |
9 | DELTA EGFR | 83026 | 0% | 100% | 4 | Search DELTA+EGFR | Search DELTA+EGFR |
10 | EGFR | 70672 | 9% | 3% | 136 | Search EGFR | Search EGFR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GAN, HK , CVRLJEVIC, AN , JOHNS, TG , (2013) THE EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III (EGFRVIII): WHERE WILD THINGS ARE ALTERED.FEBS JOURNAL. VOL. 280. ISSUE 21. P. 5350-5370 | 129 | 57% | 51 |
2 | GAN, HK , KAYE, AH , LUWOR, RB , (2009) THE EGFRVIII VARIANT IN GLIOBLASTOMA MULTIFORME.JOURNAL OF CLINICAL NEUROSCIENCE. VOL. 16. ISSUE 6. P. 748 -754 | 62 | 65% | 146 |
3 | SANTOSH, V , SRIVIDYA, MR , THOTA, B , ARIVAZHAGAN, A , THENNARASU, K , BALASUBRAMANIAM, A , CHANDRAMOULI, BA , HEGDE, AS , (2010) AGE-DEPENDENT PROGNOSTIC EFFECTS OF EGFR/P53 ALTERATIONS IN GLIOBLASTOMA: STUDY ON A PROSPECTIVE COHORT OF 140 UNIFORMLY TREATED ADULT PATIENTS.JOURNAL OF CLINICAL PATHOLOGY. VOL. 63. ISSUE 8. P. 687 -691 | 50 | 75% | 10 |
4 | KUAN, CT , WIKSTRAND, CJ , BIGNER, DD , (2001) EGF MUTANT RECEPTOR VIII AS A MOLECULAR TARGET IN CANCER THERAPY.ENDOCRINE-RELATED CANCER. VOL. 8. ISSUE 2. P. 83-96 | 53 | 73% | 189 |
5 | SHINOJIMA, N , TADA, K , SHIRAISHI, S , KAMIRYO, T , KOCHI, M , NAKAMURA, H , MAKINO, K , SAYA, H , HIRANO, H , KURATSU, J , ET AL (2003) PROGNOSTIC VALUE OF EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH GLIOBLASTOMA MULTIFORME.CANCER RESEARCH. VOL. 63. ISSUE 20. P. 6962-6970 | 45 | 69% | 330 |
6 | KORSHUNOV, A , GOLANOV, A , SYCHEVA, R , (2002) IMMUNOHISTOCHEMICAL MARKERS FOR PROGNOSIS OF CEREBRAL GLIOBLASTOMAS.JOURNAL OF NEURO-ONCOLOGY. VOL. 58. ISSUE 3. P. 217 -236 | 72 | 61% | 22 |
7 | SHAPIRO, JR , (2002) GENETIC ALTERATIONS ASSOCIATED WITH ADULT DIFFUSE ASTROCYTIC TUMORS.AMERICAN JOURNAL OF MEDICAL GENETICS. VOL. 115. ISSUE 3. P. 194-201 | 61 | 67% | 20 |
8 | BARKER, FG , SIMMONS, ML , CHANG, SM , PRADOS, MD , LARSON, DA , SNEED, PK , WARA, WM , BERGER, MS , CHEN, PC , ISRAEL, MA , ET AL (2001) EGFR OVEREXPRESSION AND RADIATION RESPONSE IN GLIOBLASTOMA MULTIFORME.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. VOL. 51. ISSUE 2. P. 410-418 | 46 | 70% | 152 |
9 | ZAWROCKI, A , BIERNAT, W , (2005) EPIDERMAL GROWTH FACTOR RECEPTOR IN GLIOBLASTOMA.FOLIA NEUROPATHOLOGICA. VOL. 43. ISSUE 3. P. 123-132 | 51 | 65% | 8 |
10 | GULATI, S , YTTERHUS, B , GRANLI, US , GULATI, M , LYDERSEN, S , TORP, SH , (2010) OVEREXPRESSION OF C-ERBB2 IS A NEGATIVE PROGNOSTIC FACTOR IN ANAPLASTIC ASTROCYTOMAS.DIAGNOSTIC PATHOLOGY. VOL. 5. ISSUE . P. - | 40 | 69% | 13 |
Classes with closest relation at Level 1 |